Items where Author is "Shparyk, Yaroslav"

Miles, David and Cameron, David and Bondarenko, Igor and Manzyuk, Lyudmila and Alcedo, Juan Carlos and Lopez, Roberto Ivan and Im, Seock-Ah and Canon, Jean-Luc and Shparyk, Yaroslav and Yardley, Denise A and Masuda, Norikazu and Ro, Jungsil and Denduluri, Neelima and Hubeaux, Stanislas and Quah, Cheng and Bais, Carlos and O'Shaughnessy, Joyce (2017) Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. European journal of cancer, 70. pp. 146-155. ISSN 1879-0852

Robertson, John F R and Bondarenko, Igor M and Trishkina, Ekaterina and Dvorkin, Mikhail and Panasci, Lawrence and Manikhas, Alexey and Shparyk, Yaroslav and Cardona-Huerta, Servando and Cheung, Kwok-Leung and Philco-Salas, Manuel Jesus and Ruiz-Borrego, Manuel and Shao, Zhimin and Noguchi, Shinzaburo and Rowbottom, Jacqui and Stuart, Mary and Grinsted, Lynda M and Fazal, Mehdi and Ellis, Matthew J (2016) Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. The Lancet, 388 (10063). pp. 2997-3005. ISSN 1474-547X

Hawkins, Robert E. and Gore, Martin and Shparyk, Yaroslav and Bondar, Vladimir and Gladkov, Oleg and Ganev, Tosho and Harza, Mihai and Polenkov, Serhii and Bondarenko, Igor and Karlov, Petr and Karyakin, Oleg and Khasanov, Rustem and Hedlund, Gunnar and Forsberg, Goran and Nordle, Orjan and Eisen, Timothy (2016) A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis. Clinical Cancer Research, 22 (13). pp. 3172-3181. ISSN 1078-0432 (print), 1557-3265 ( online)

Eisen, Tim and Shparyk, Yaroslav and Macleod, Nicholas and Jones, Robert and Wallenstein, Gudrun and Temple, Graham and Khder, Yasser and Dallinger, Claudia and Studeny, Matus and Loembe, Arsene-Bienvenu and Bondarenko, Igor (2013) Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study. Investigational New Drugs, Vol.31 (Iss 5). pp. 1283-1293. ISSN 0167-6997 (Print) 1573-0646 (Online)